From the University of Pennsylvania, Philadelphia, here is a report of a recent small scale experimental application of a vaccine in early HER2/neu positive cancer patients:
http://cancerres.aacrjournals.org/cg....CAN-06-4038v1
Published online first on February 9, 2007
Cancer Research, 10.1158/0008-5472.CAN-06-4038
Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion
Hybrid Mode
